2,176
Participants
Start Date
November 4, 2021
Primary Completion Date
January 17, 2022
Study Completion Date
January 17, 2022
No Intervention
This is a cross-sectional non-product related survey including peri- and post-menopausal women with moderate to severe VMS associated with menopause.
IQVIA, London
Astellas Pharma Europe Ltd.
INDUSTRY